US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
LENSAR, Inc. - Common Stock
(NQ:
LNSR
)
6.750
+0.180 (+2.74%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LENSAR, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
↗
August 20, 2026
ALLY system placements accelerate as recurring revenue hits 83% of total sales.
Via
The Motley Fool
Topics
Earnings
World Trade
These stocks have an unusual volume in today's session
↗
August 14, 2026
Via
Chartmill
LENSAR Q2 Earnings Call Highlights
↗
August 13, 2026
LENSAR (NASDAQ:LNSR) reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end...
Via
MarketBeat
Topics
Earnings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 13, 2026
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased...
Via
Benzinga
LENSAR Inc (NASDAQ:LNSR) Q1 2026 Revenue Misses Estimates as ALLY System Backlog Grows
↗
May 08, 2026
Via
Chartmill
Lensar (LNSR) Q1 2026 Earnings Transcript
↗
June 01, 2026
Lensar (LNSR) Q1 2026 Earnings Transcript
Via
The Motley Fool
Lensar (LNSR) Q4 2025 Earnings Transcript
↗
June 01, 2026
Lensar (LNSR) Q4 2025 Earnings Transcript
Via
The Motley Fool
Topics
Economy
World Trade
LENSAR Q1 Earnings Call Highlights
↗
May 08, 2026
LENSAR (NASDAQ:LNSR) executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on...
Via
MarketBeat
Topics
Earnings
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback
↗
March 16, 2026
Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23.
Via
Stocktwits
Lensar (LNSR) Q2 Revenue Rises 10%
↗
August 07, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
June 15, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SVT, LNSR, ICAD, SSBK on Behalf of Shareholders
June 10, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, SWTX, ICAD, SSBK on Behalf of Shareholders
June 04, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
June 03, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ICAD, BSGM, SSBK on Behalf of Shareholders
June 03, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
↗
May 29, 2025
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Landsea Homes Corporation (Nasdaq - LSEA), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq – FARO)
May 19, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNB, LNSR, TASK on Behalf of Shareholders
May 18, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, LNSR, AVDX on Behalf of Shareholders
May 13, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Landsea Homes Corporation (Nasdaq - LSEA), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq – FARO)
May 13, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FARO, AVDX, LNSR on Behalf of Shareholders
May 08, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hall of Fame Resort & Entertainment Company (Nasdaq – HOFV), LENSAR, Inc. (Nasdaq - LNSR), AvidXchange Holdings, Inc. (Nasdaq – AVDX), FARO Technologies, Inc. (Nasdaq
May 08, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders
April 21, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (Nasdaq - GB)
April 21, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (NYSE - GB)
April 16, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
March 26, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
March 26, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Alcon Eyes Surgical Edge With LENSAR Buyout: Details
↗
March 24, 2025
Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract...
Via
Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders
March 24, 2025
From
Ademi & Fruchter LLP
Via
Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders
March 24, 2025
From
Halper Sadeh LLC
Via
Business Wire
< Previous
1
2
3
4
5
Next >
